Vireo Growth (VREOF) Long-Term Debt Issuances (2021 - 2026)

Vireo Growth (VREOF) reported Long-Term Debt Issuances of $4.5 million for Q1 2026, up 400.0% on a YoY basis from $900000.0 in Q1 2025, and up 103.94% sequentially from -$114.2 million in Q4 2025.

Vireo Growth (VREOF) Long-Term Debt Issuances (2021 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 6 years of Long-Term Debt Issuances data on file, last reported at $4.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Long-Term Debt Issuances rose 400.0% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (up 40.14% YoY), and the FY2025 full-year result was $10.0 million, up 1.48% from the prior year.
  • Long-Term Debt Issuances advanced to $4.5 million in Q1 2026, from -$114.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $124.5 million in Q3 2025 to a low of -$114.2 million in Q4 2025.
  • A 5-year average of $3.3 million and a median of $1.0 million in 2023 frame the typical range for Long-Term Debt Issuances.
  • Peak annual rise in Long-Term Debt Issuances reached 345682.24% in 2025, while the deepest fall reached 9766.67% in 2025.
  • Tracing VREOF's Long-Term Debt Issuances over 5 years: stood at $894937.0 in 2022, then increased by 11.74% to $1.0 million in 2023, then surged by 775.63% to $8.8 million in 2024, then slumped by 1404.45% to -$114.2 million in 2025, then jumped by 103.94% to $4.5 million in 2026.
  • Business Quant data shows VREOF's Long-Term Debt Issuances at $4.5 million in Q1 2026, -$114.2 million in Q4 2025, and $124.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.64 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 4.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.50 Mn
Mar 31, 2026 4.50 Mn
Dec 31, 2025 -114.22 Mn
Dec 31, 2025 -114.22 Mn
Sep 30, 2025 124.48 Mn
Sep 30, 2025 124.48 Mn
Jun 30, 2025 -1.16 Mn
Jun 30, 2025 -1.16 Mn
Mar 31, 2025 900,000.00
Mar 31, 2025 900,000.00
Dec 31, 2024 8.76 Mn
Dec 31, 2024 8.76 Mn
Sep 30, 2024 36,000.00
Sep 30, 2024 36,000.00
Jun 30, 2024 12,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 1.05 Mn
Mar 31, 2024 1.05 Mn
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn